IDiyas

For the Inventor, By the Inventor

Mount Royal, Canada

Hans U Immer

USPTO Granted Patents = 20

Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 85(Granted Patents)


Location History:

  • Montreal, C (1976)
  • Mt. Royal, CA (1977 - 1978)
  • Montreal, CA (1979)
  • St. Laurent, CA (1981)
  • Mount Royal, CA (1976 - 1983)

Company Filing History:

goldMedal11 out of 1,567 
 
American Home Products Corporation
 patents
silverMedal9 out of 117 
 
Ayerst, Mckenna & Harrison, Inc.
 patents

Years Active: 1976-1983

Loading Chart...
20 patents (USPTO):Explore Patents
1. 4401656 - N-Substituted dimeric cyclopeptide derivatives (1983-08-30),
2. 4351828 - N-Substituted cyclopeptide derivatives (1982-09-28),
3. 4301066 - Preparation of (D-Trp .sup.6)-LH-RH via the heptapeptide (1981-11-17),
4. 4252795 - N-substituted dimeric cyclopeptide derivatives and preparation thereof (1981-02-24),
5. 4244947 - Carba decapeptide derivatives of [TYR.sup.6 ]-somatostatin (1981-01-13),
6. 4237045 - N-substituted cyclopeptide derivatives and preparation thereof (1980-12-02),
7. 4216209 - Tripeptide angiotensin converting enzyme inhibitors (1980-08-05),
8. 4213895 - N-[N-[N-[ (1980-07-22),
9. 4159980 - Process for preparing the releasing hormone of luteinizing hormone (LH) (1979-07-03),
10. 4118380 - Decapeptide analogs of somatostatin (1978-10-03),
11. 4093713 - Dipeptide derivatives with central nervous system activity and (1978-06-06),
12. 4093610 - Process for producing triglycyl-lysine vasopressin and intermediates (1978-06-06),
13. 4081530 - Extended chain derivatives of somatostatin (1978-03-28),
14. 4033974 - Pyridylmethyl esters of N-(phenoxyalkanoyl)peptide derivatives (1977-07-05),
15. 4020157 - Shortened analogs of somatostatin (1977-04-26),

Title: Hans U Immer - A Pioneer in Innovation

Introduction:

Hans U Immer is a renowned inventor whose groundbreaking work has left a lasting impact on the field of technology. With a location in Mount Royal, CA, Immer has been at the forefront of innovation, holding an impressive number of 19 patents to his name.

Latest Patents:

Immer's latest patents include the N-Substituted dimeric cyclopeptide derivatives and the N-Substituted cyclopeptide derivatives. These compounds have shown promise in treating microbial infections and as antibacterial and antifungal agents, showcasing Immer's versatility in developing impactful solutions in the healthcare industry.

Career Highlights:

Throughout his career, Immer has made significant contributions to innovation while working with reputable companies such as American Home Products Corporation and Ayerst, Mckenna & Harrison, Inc. His expertise and visionary approach have led to the successful development of cutting-edge technologies.

Collaborations:

Immer's collaborations with esteemed colleagues like Manfred K Gotz and Amedeo Failli have further enriched his work, bringing together diverse skill sets and perspectives to drive innovation forward. These partnerships have resulted in groundbreaking inventions that have set new standards in the industry.

Conclusion:

In conclusion, Hans U Immer stands as a true pioneer in the world of innovation, with a legacy that continues to inspire and drive progress in the ever-evolving field of technology. His dedication to excellence and his ability to push boundaries have cemented his reputation as a leading inventor whose impact will be felt for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…